Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Creo Medical Group FY22 results and recent funding - Proactive Research Analyst

Creo Medical Group FY22 results and recent funding - Proactive Research Analyst

Proactive Research Analyst John Savin gives the highlights from his latest research note on UK-based medical device company Creo Medical Group PLC (AIM:CREO)

Savin talks about the company's recent performance and key products, before moving on to look at how it is positioned for the future.

He also touches on a recent placing that generated a net £32 million.

Click here to read the report